Why does content need a strategy?

Liz Inskip, Adwoa Baah|7th March 2016

In our previous article, we talked about how to mature your organisation’s approach to content strategy. We covered off three key things you can do to move your company forward in 2016. However, not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy?

In this article, Content Marketing Manager Liz Inskip and guest blogger Adwoa Baah explain how having a documented strategy for content creation, distribution, management, and governance will empower your brand teams and create organisational efficiencies.

 

A documented strategy empowers the creation of purposeful, focused content

A documented strategy for content creation ensures that all content serves a strategic purpose, and is in line with business objectives, as well as customer needs. When content is brought into the strategic process at the beginning, it can shape thinking and drive the overall brand strategy.

For example, some of our clients have the problem of having too much content and no content owners. There isn’t a documented strategy in place for content creation, so new content is constantly being created to meet brand teams’ needs. This tends to mean that there is a proliferation of content, but no strategic guidance around how that content should be created or understanding of how each piece of content will meet business objectives and customer needs. In these cases, a documented strategy has empowered the brand teams to create less content, but the content that was created was purposeful and served a strategic purpose.

 

Download the full article in PDF by clicking the button below.

Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

read more

Understanding the evolving CAR-T market

Ditte Funding, Maria Katsarou, Natasha Cowan|1st November 2019

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

read more

How ready are you for launch?

Daphne Chung, Natasha Cowan|25th October 2019

Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.

read more